- Search results for SYN-1172-M100
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
14 products were found matching "SYN-1172-M100"!
Close filters
Filter by:
No results were found for the filter!
Item number: SYN-1217-M100
Solid. Soluble in DMSO. S49076 is a novel, potent inhibitor of MET, AXL/MER and FGFR1/2/3. It can potently block cellular phosphorylation of MET, AXL and FGFRs and inhibit downstream signalling in vitro and in vivo. S49076 can inhibit the proliferation of MET- and FGFR2-dependent gastric cancer cells, block...
Keywords: | S-49076 . HCl, (Z)-3-((3-((4-(Morpholinomethyl)-1H-pyrrol-2-yl)methylene)-2-oxoindolin-5-yl)methyl)thiazolidine-2,4-dione... |
Application: | MET AXL/MER & FGFR1/2/3 inhibitor |
CAS | 1265965-19-2 |
MW: | 475,0 D |
Please request pricing for this article.
Item number: SYN-1122-M100
Slightly soluble (<1mg/ml) in DMSO or ethanol. Tamatinib effectively inhibits BCR signaling in vivo, resulting in reduced proliferation and survival of the malignant B cells and significantly prolonged survival of the treated animals. Target: BCR , Kinase Group: PTK , Substrate: Tyrosine
Keywords: | Fostamatinib, Tamatinib fosdium, FosD, R-788 |
Application: | Syk inhibitor |
CAS | 1025687-58-4 |
MW: | 624,5 D |
Please request pricing for this article.
Item number: SYN-1162-M100
Soluble in DMSO or ethanol. MK-2206 is a highly selective inhibitor of Akt1, Akt2 and Akt3 with IC(50) of 8nM, 12nM and 65nM, respectively. Target: AKT , Kinase Group: AGC , Substrate: Serine-Threonine
Keywords: | MK2206 |
Application: | AKT inhibitor |
CAS | 1032350-13-2 |
MW: | 480,4 D |
Please request pricing for this article.
Item number: SYN-1173-M100
Soluble in DMSO or ethanol. SCH900776 is a selective Chk1 inhibitor with an IC(50) of 3nM. It shows 50-fold selectivity for Chk1 versus Chk2. Target: Chk1 , Kinase Group: CAMK , Substrate: Serine-Threonine
Keywords: | MK-8776 |
Application: | Chk1 inhibitor |
CAS | 891494-63-6 |
MW: | 376,3 D |
Please request pricing for this article.
Item number: SYN-1179-M100
Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. Bafetinib (INNO-406) is a potent and selective dual Bcr-Abl, Lyn inhibitor with IC(50) values of 5.8nM and 19nM, respectively.
Keywords: | NS-187, INNO-406 |
Application: | Bcr-Abl / Lyn inhibitor |
CAS | 859212-16-1 |
MW: | 576,6 D |
Please request pricing for this article.
Item number: SYN-1182-M100
Soluble in DMSO. CX6258 is a potent inhibitor of Pim-1, Pim-2 and Pim-3 with IC(50) values of 5, 25 and 16nM, respectively. Target: PKC - PKC alpha, , Kinase Group: STE , Substrate: Serine-Threonine
Keywords: | CX6258 |
Application: | Pim-1 / Pim-2 / Pim-3 inhibitor |
CAS | 1202916-90-2 |
MW: | 461,9 D |
Please request pricing for this article.
Item number: SYN-1170-M100
Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. GSK1120212 (JTP-74057, trametinib) is a highly specific and potent MEK1 and MEK2 inhibitor with IC(50) values of 0.92nM and 1.8nM respectively. Target: MEK1 - MEK2 , Kinase Group: STE , Substrate: Serine-Threonine
Keywords: | JTP-74057, GSK212, Trametinib |
Application: | MEK1 / MEK2 inhibitor |
CAS | 871700-17-3 |
MW: | 615,4 D |
Please request pricing for this article.
Item number: SYN-1175-M100
Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. IPI-145 is a potent, oral inhibitor of Class I phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma (IC(50) of 243 pM and 50nM), and is clinically active in patients with advanced hematological malignancies. Target: PI3K , Kinase Group: Atypical (PIKK) ,...
Keywords: | IPI 145 |
Application: | PI3K gamma / delta inhibitor |
CAS | 1201438-56-3 |
MW: | 416,9 D |
Please request pricing for this article.
Item number: SYN-1072-M100
Soluble in DMSO or ethanol. The cytokine Tumor necrosis factor-alpha (TNF-alpha) is secreted by activated monocytes/macrophages and T lymphocytes and has been implicated in several disease states, including rheumatoid arthritis, inflammatory bowel disease, septic shock, and osteoporosis. Monocyte/macrophage...
Keywords: | RWJ67657 |
Application: | p38 inhibitor |
CAS | 215303-72-3 |
MW: | 425,5 D |
Please request pricing for this article.
Item number: SYN-1132-M100
Soluble in DMSO. S6K-18 is a highly selective inhibitor of S6K1, with an IC(50) of 52nM. Target: S6K , Kinase Group: AGC , Substrate: Serine-Threonine
Keywords: | S6K18 |
Application: | S6K inhibitor |
CAS | 1265789-88-5 |
MW: | 358,4 D |
Please request pricing for this article.
Item number: SYN-1152-M100
Soluble in DMSO or ethanol. NVP-BGJ398 inhibits FGFR-WT, FGFR2-WT, FGFR3-K650E, FGFR3-S249C and FGFR4-WT with IC(50) values of 4.6, 4.9, 5, 5 and 168nM, respectively. Target: FGFR , Kinase Group: RTK , Substrate: Tyrosine
Keywords: | NVPBGJ398 |
Application: | FGFR inhibitor |
CAS | 872511-34-7 |
MW: | 560,5 D |
Please request pricing for this article.
Item number: SYN-1142-M100
Soluble in DMSO or ethanol. BMS-599626 is an orally bioavailable, highly selective and potent pan-HER kinase inhibitor. It inhibits HER1 and HER2 with IC(50) values of 20 and 30nM, respectively. Target: EGFR - HER2 , Kinase Group: RTK , Substrate: Tyrosine
Keywords: | AC-480, BMS599626 |
Application: | EGFR / HER2 inhibitor |
CAS | 714971-09-2 |
MW: | 530,6 D |
Please request pricing for this article.